Paratek Pharmaceuticals Inc (PRTK) Insider Trading
- $6,307,795.00
- $7,820,688.93
- Aug. 9, 2023
- Evan Loh
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 9, 2023 | Insider | 27,603 | $2.20 | Sell | $60,726.60 | |
Aug. 9, 2023 | Chairman | 31,250 | $2.20 | Sell | $68,750.00 | |
Aug. 9, 2023 | General Counsel | 34,526 | $2.20 | Sell | $75,957.20 | |
Aug. 9, 2023 | CEO | 48,967 | $2.20 | Sell | $107,727.40 | |
Feb. 21, 2023 | Director | 7,000 | $1.90 | Sell | $13,300.00 | |
Dec. 21, 2022 | Insider | 6,750 | $1.99 | Sell | $13,432.50 | |
Dec. 21, 2022 | Chairman | 15,750 | $1.99 | Sell | $31,342.50 | |
Dec. 21, 2022 | CEO | 23,489 | $1.99 | Sell | $46,743.11 | |
Dec. 21, 2022 | General Counsel | 7,007 | $1.99 | Sell | $13,943.93 | |
Dec. 12, 2022 | Insider | 3,820 | $1.98 | Sell | $7,563.60 | |
Dec. 12, 2022 | CEO | 37,831 | $1.98 | Sell | $74,905.38 | |
Dec. 12, 2022 | Chairman | 19,484 | $1.98 | Sell | $38,578.32 | |
Dec. 12, 2022 | General Counsel | 14,410 | $1.98 | Sell | $28,531.80 | |
Oct. 28, 2022 | General Counsel | 4,382 | $3.47 | Sell | $15,205.54 | |
Oct. 28, 2022 | Chairman | 6,000 | $3.47 | Sell | $20,820.00 | |
Oct. 28, 2022 | Insider | 4,563 | $3.47 | Sell | $15,833.61 | |
Oct. 28, 2022 | CEO | 8,805 | $3.47 | Sell | $30,553.35 | |
Aug. 9, 2022 | Chairman | 28,637 | $2.66 | Sell | $76,174.42 | |
Aug. 9, 2022 | CEO | 44,519 | $2.66 | Sell | $118,420.54 | |
Aug. 9, 2022 | Insider | 19,608 | $2.66 | Sell | $52,157.28 | |
Aug. 9, 2022 | General Counsel | 22,453 | $2.66 | Sell | $59,724.98 | |
Dec. 15, 2021 | Chairman | 17,819 | $4.27 | Sell | $76,087.13 | |
Dec. 15, 2021 | General Counsel | 17,178 | $4.27 | Sell | $73,350.06 | |
Dec. 15, 2021 | CEO | 49,259 | $4.27 | Sell | $210,335.93 | |
Dec. 15, 2021 | Insider | 15,780 | $4.27 | Sell | $67,380.60 | |
Dec. 13, 2021 | Chairman | 5,059 | $4.42 | Sell | $22,360.78 | |
Dec. 13, 2021 | CEO | 13,983 | $4.42 | Sell | $61,804.86 | |
Dec. 13, 2021 | Insider | 4,479 | $4.42 | Sell | $19,797.18 | |
Dec. 13, 2021 | General Counsel | 4,876 | $4.42 | Sell | $21,551.92 | |
Aug. 17, 2021 | Insider | 8,766 | $5.12 | Sell | $44,881.92 | |
Aug. 17, 2021 | General Counsel | 9,692 | $5.12 | Sell | $49,623.04 | |
Aug. 17, 2021 | Chairman | 32,030 | $5.12 | Sell | $163,993.60 | |
Aug. 17, 2021 | CEO | 33,931 | $5.12 | Sell | $173,726.72 | |
June 4, 2021 | General Counsel | 7,561 | $9.70 | Sell | $73,341.70 | |
June 4, 2021 | Chairman | 34,364 | $9.70 | Sell | $333,330.80 | |
June 4, 2021 | Insider | 17,182 | $9.70 | Sell | $166,665.40 | |
Dec. 14, 2020 | Insider | 12,855 | $6.71 | Sell | $86,257.05 | |
Dec. 14, 2020 | CEO | 26,415 | $6.71 | Sell | $177,244.65 | |
Dec. 14, 2020 | General Counsel | 6,842 | $6.71 | Sell | $45,909.82 | |
Dec. 14, 2020 | Chairman | 26,063 | $6.71 | Sell | $174,882.73 | |
Dec. 11, 2020 | Insider | 9,045 | $6.95 | Sell | $62,862.75 | |
Dec. 11, 2020 | General Counsel | 4,814 | $6.95 | Sell | $33,457.30 | |
Dec. 11, 2020 | Chairman | 18,337 | $6.95 | Sell | $127,442.15 | |
Dec. 11, 2020 | CEO | 18,585 | $6.95 | Sell | $129,165.75 | |
Nov. 13, 2020 | CEO | 20,928 | $5.93 | Sell | $124,103.04 | |
Nov. 13, 2020 | Chairman | 26,250 | $5.93 | Sell | $155,662.50 | |
Nov. 13, 2020 | General Counsel | 6,892 | $5.93 | Sell | $40,869.56 | |
Nov. 13, 2020 | Insider | 8,357 | $5.93 | Sell | $49,557.01 | |
May 12, 2020 | VP | 4,666 | $4.75 | Sell | $22,163.50 | |
May 12, 2020 | Insider | 6,198 | $4.75 | Sell | $29,440.50 |
Insiders are both buying and selling Paratek Pharmaceuticals Inc stock.
The insider traders at Paratek Pharmaceuticals Inc are: Evan Loh, Michael Bigham, William M Haskel, Adam Woodrow, Randall B Brenner, Douglas W Pagan, Roumell Asset Management, Llc, Jeffrey Stein, Hbm Healthcare Investments (Ca, Fund Iv L.P. Omega, Robert S Radie, and Thomas John Dietz
The most active insider trader at Paratek Pharmaceuticals Inc is Evan Loh with 24 trades.
Michael Bigham has sold the most Paratek Pharmaceuticals Inc stock with a total value of $2,275,744.09.
Fund Iv L.P. Omega has bought the most Paratek Pharmaceuticals Inc stock with a total value of $11,999,988.00.
The most recent insider trade for Paratek Pharmaceuticals Inc was on Aug. 9, 2023.
The single biggest insider buy for Paratek Pharmaceuticals Inc was from Fund Iv L.P. Omega with a total value of $5,999,994.00 on June 27, 2016.
The single biggest insider sell for Paratek Pharmaceuticals Inc was from Hbm Healthcare Investments (Ca with a total value of $632,835.00 on May 29, 2015.